Hanna, Catherine R.O’Cathail, Sean M.Graham, Janet S.Saunders, MarkSamuel, LeslieHarrison, MarkDevlin, LynseyEdwards, JoanneGaya, Daniel R.Kelly, Caroline A.Lewsley, Liz AnneMaka, NooriMorrison, PaulaDinnett, LouiseDillon, SusanGourlay, JacquelinePlatt, Jonathan J.Thomson, FionaAdams, Richard A.Roxburgh, Campbell S.D.2022-01-142022-01-142021-12Hanna, C R, O’Cathail, S M, Graham, J S, Saunders, M, Samuel, L, Harrison, M, Devlin, L, Edwards, J, Gaya, D R, Kelly, C A, Lewsley, L A, Maka, N, Morrison, P, Dinnett, L, Dillon, S, Gourlay, J, Platt, J J, Thomson, F, Adams, R A & Roxburgh, C S D 2021, 'Correction to : Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT) (Radiation Oncology, (2021), 16, 1, (163), 10.1186/s13014-021-01888-1)', Radiation Oncology, vol. 16, 230. https://doi.org/10.1186/s13014-021-01941-z1748-717XORCID: /0000-0002-8402-8670/work/106597566https://hdl.handle.net/2164/17879Funding Information: After publication of this article, the authors reported that the Funding information section was incomplete. The following should have been added: “This work was supported by CRUK (Grant Number C61974/A2429).”1579329engSDG 3 - Good Health and Well-beingR Medicine (General)OncologyRadiology Nuclear Medicine and imagingCancer Research UKC61974/A2429R1Journal item10.1186/s13014-021-01941-zhttps://www.scopus.com/pages/publications/85120734988